Cognitive Deficits
24
2
2
15
Key Insights
Highlights
Success Rate
79% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
16.7%
4 terminated out of 24 trials
78.9%
-7.6% vs benchmark
13%
3 trials in Phase 3/4
20%
3 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (24)
Web-based Application to Test for Long-term Cognitive Deficits in BioCog Patients
Neuromodulation and Attention Deficits in MDD
Self Treatment With an Electronic Device for Cognitive Rehabilitation in Patients With Subacute Stroke
Treating Verbal Memory Deficits Following Chemotherapy for Breast Cancer
Augmentation of Working Memory Training With Transcranial Direct Current Stimulation in Patients With Schizophrenia
Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine
Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis
Acupuncture Treatment for Improving Alzheimer's Dementia
Analysis of TCLT in TBI Patients: a Prospective, Randomized Controlled Trial
Can Cognitive Training Decrease Reactive Aggression?
Characterizing and Predicting Drug Effects on Cognition
Attentional Bias Modification Through Eye-tracker Methodology (ABMET)
Smart Autonomous Neuro-Rehabilitation System
Effects of Multiple Concussions in Retired NHL Players
Cognitive Remediation Therapy Within a Secure Forensic Setting
Gabapentin Treatment of Cannabis Dependence
Methylphenidate Treatment of Attention Deficits in Epilepsy
Effects of Cognitive Behavioural Therapy and Exercise on Stress and Cognitive Deficits in Multiple Sclerosis
Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya
Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia